shaw-sexdeterminant-2013.pdf (511.75 kB)
Sex as a determinant of relapse incidence and progressive course of multiple sclerosis
journal contributionposted on 2013-01-01, 00:00 authored by T Kalincik, V Vivek, V Jokubaitis, J Lechner-Scott, M Trojano, G Izquierdo, A Lugaresi, F Grand-Maison, R Hupperts, C Oreja-Guevara, R Bergamaschi, G Iuliano, R Alroughani, P Van, M Amato, M Slee, F Verheul, R Fernandez-Bolanos, M Fiol, S La, E Cristiano, O Gray, J Cabrera-Gomez, V Shaygannejad, J Herbert, S Vucic, M Needham, T Petkovska-Boskova, C A Sirbu, P Duquette, M Girard, P Grammond, C Boz, G Giuliani, M Rio, M Barnett, S Flechter, F Moore, B Singhal, E Bacile, M Saladino, Cameron ShawCameron Shaw, E Skromne, D Poehlau, N Vella, T Spelman, D Liew, T Kilpatrick, H Butkueven
The aim of this work was to evaluate sex differences in the incidence of multiple sclerosis relapses; assess the relationship between sex and primary progressive disease course; and compare effects of age and disease duration on relapse incidence. Annualized relapse rates were calculated using the MSBase registry. Patients with incomplete data or <1 year of follow-up were excluded. Patients with primary progressive multiple sclerosis were only included in the sex ratio analysis. Relapse incidences over 40 years of multiple sclerosis or 70 years of age were compared between females and males with Andersen-Gill and Tweedie models. Female-to-male ratios stratified by annual relapse count were evaluated across disease duration and patient age and compared between relapse-onset and primary progressive multiple sclerosis. The study cohort consisted of 11 570 eligible patients with relapse-onset and 881 patients with primary progressive multiple sclerosis. Among the relapse-onset patients (82 552 patient-years), 48 362 relapses were recorded. Relapse frequency was 17.7% higher in females compared with males. Within the initial 5 years, the female-to-male ratio increased from 2.3:1 to 3.3:1 in patients with 0 versus ≥4 relapses per year, respectively. The magnitude of this sex effect increased at longer disease duration and older age (P < 10−12). However, the female-to-male ratio in patients with relapse-onset multiple sclerosis and zero relapses in any given year was double that of the patients with primary progressive multiple sclerosis. Patient age was a more important determinant of decline in relapse incidence than disease duration (P < 10−12). Females are predisposed to higher relapse activity than males. However, this difference does not explain the markedly lower female-to-male sex ratio in primary progressive multiple sclerosis. Decline in relapse activity over time is more closely related to patient age than disease duration.